PCDHGC3 hypermethylation as a potential biomarker of intestinal neuroendocrine carcinomas.
Cubiella T, Celada L, San-Juan-Guardado J, Rodríguez-Aguilar R, Suárez-Priede Á, Poch M, Dominguez F, Fernández-Vega I, Montero-Pavón P, Fraga MF, Nakatani Y, Takata S, Yachida S, Valdés N, Chiara MD.
Cubiella T, et al. Among authors: nakatani y.
J Pathol. 2024 May 25. doi: 10.1002/path.6291. Online ahead of print.
J Pathol. 2024.
PMID: 38795318